Organogenesis Holdings (ORGO) Construction in Progress (2023 - 2025)
Organogenesis Holdings' (ORGO) quarterly Construction in Progress came in at $26.7 million in Q4 2025, up 22.19% year-on-year from $21.9 million in Q4 2024, and down 2.9% quarter-over-quarter from $27.5 million in Q3 2025.
Organogenesis Holdings (ORGO) Construction in Progress (2023 - 2025) Analysis & Trends
Organogenesis Holdings' Construction in Progress history runs 3 years deep, the most recent figure standing at $26.7 million for Q4 2025.
- On a quarterly basis, Construction in Progress rose 22.19% year-over-year to $26.7 million in Q4 2025; TTM through Dec 2025 was $26.7 million, a 22.19% increase from a year earlier, with the FY2025 full-year figure at $26.7 million, up 22.19% from the prior year.
- Construction in Progress fell to $26.7 million in Q4 2025 per ORGO's latest filing, from $27.5 million in the prior quarter.
- Across five years, Construction in Progress topped out at $59.1 million in Q4 2023 and bottomed at $20.6 million in Q3 2024.
- The 3-year median for Construction in Progress is $23.9 million (2025), against an average of $29.1 million.
- Across the five-year window, Construction in Progress tumbled 62.95% in 2024 and soared 33.66% in 2025, its largest moves.
- Year by year, Construction in Progress stood at $59.1 million in 2023, then tumbled by 62.95% to $21.9 million in 2024, then advanced by 22.19% to $26.7 million in 2025.
- Per Business Quant, the three latest ORGO Construction in Progress figures stand at $26.7 million (Q4 2025), $27.5 million (Q3 2025), and $23.9 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Organogenesis Holdings | 310.55 Mn | 218.45 Mn | 11.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.74 Mn |
| Sep 30, 2025 | 27.54 Mn |
| Jun 30, 2025 | 23.94 Mn |
| Mar 31, 2025 | 23.76 Mn |
| Dec 31, 2024 | 21.89 Mn |
| Sep 30, 2024 | 20.61 Mn |
| Dec 31, 2023 | 59.07 Mn |